How much profit has MorphoSys made this year?
MorphoSys has made -143.2 M EUR this year.
MorphoSys Net Income 2024
MorphoSys Net Income
-143.2 M EUR
MorphoSys Dividend yield
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's profit amounted to -143.2 M EUR, a -24.53% increase from the -189.73 M EUR profit recorded in the previous year.
The MorphoSys Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2030e | 44.43 |
| 2029e | 24.4 |
| 2028e | 185.87 |
| 2027e | 163.56 |
| 2026e | 14.72 |
| 2025e | -111.2 |
| 2024e | -143.2 |
| 2023 | -189.73 |
| 2022 | -151.06 |
| 2021 | -514.46 |
| 2020 | 97.89 |
| 2019 | -103.01 |
| 2018 | -56.17 |
| 2017 | -69.83 |
| 2016 | -60.38 |
| 2015 | 14.9 |
| 2014 | -3.01 |
| 2013 | 13.3 |
| 2012 | 1.9 |
| 2011 | 8.2 |
| 2010 | 9.2 |
| 2009 | 9 |
| 2008 | 13.2 |
| 2007 | 11.5 |
| 2006 | 6 |
| 2005 | 4.7 |
| 2004 | 0.3 |
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding MorphoSys's Profit Margins
The profit margins of MorphoSys represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of MorphoSys's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating MorphoSys's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
MorphoSys's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When MorphoSys’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about MorphoSys Stock
How has the profit developed compared to last year?
The profit has increased by -24.53% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does MorphoSys publish its earnings?
MorphoSys publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of MorphoSys?
The profits of MorphoSys are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of MorphoSys?
You can learn more about the earnings of MorphoSys by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 4/30/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
